《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
肠内营养联合同步放化疗对局部晚期宫颈癌患者 营养状况与免疫功能的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R737.33

基金项目:


Effects of enteral nutrition combined with concurrent radiation and chemotherapy on nutritional status and immune function of patients with locally advanced cervical cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨肠内营养联合同步放化疗对局部晚期宫颈癌患者营养状况与 CD4+ 、CD8+ 百分比、CD4+ /CD8+ 比值的影响。方 法 按照随机数字表法将徐州医科大学第二附属医院 2017 年 3 月至 2021 年 3 月收治的局部晚期宫颈癌患者 62 例分为两组,各 31 例。 予以对照组患者实施常规营养指导联合同步放化疗治疗,研究组患者在对照组的基础上联合肠内营养治疗,21 d 为 1 个治疗周期,两组 患者均治疗 2 个周期。比较两组患者治疗后临床疗效与营养达标率,治疗前后血红蛋白(Hb)、白蛋白(ALB)、前白蛋白(PA)水平, CD4+ 、CD8+ 百分比及 CD4+ /CD8+ 比值,以及治疗期间不良反应发生情况。结果 两组患者治疗后的近期疗效与治疗期间国际肿瘤化疗 药物不良反应评价系统分级≥Ⅲ级的恶心、呕吐不良反应发生率经比较,差异均无统计学意义(均P>0.05);与治疗前比,治疗后两组 患者血清 Hb、ALB、PA 水平均显著降低,且研究组显著低于对照组;营养总达标率均显著升高,且研究组显著高于对照组;与治疗前比, 治疗后研究组患者 CD4+ 百分比与 CD4+ /CD8+ 比值均显著升高,而对照组均显著降低,且研究组显著高于对照组;研究组患者 CD8+ 百 分比显著降低,而对照组显著升高,且研究组显著低于对照组;治疗期间,研究组患者国际肿瘤化疗药物不良反应评价系统分级≥Ⅲ级 的骨髓抑制、腹痛及腹泻不良反应发生率均显著低于对照组(均P

    Abstract:

    Objective? To investigate the effect of enteral nutrition combined with concurrent radiotherapy and chemotherapy on the nutritional status, percentage of CD4+ , CD8+ , and CD4+ /CD8+ ratio of patients with locally advanced cervical cancer. Methods 62 patients with locally advanced cervical cancer admitted to The Second Affiliated Hospital of Xuzhou Medical University from March 2017 to March 2021 were divided into two groups according to the random number table method, with 31 cases in each group. Patients in the control group were given conventional nutritional guidance combined with concurrent radiotherapy and chemotherapy, and patients in the research group were treated combined with enteral nutrition therapy on the basis of the control group. 21 days was a treatment cycle, and both groups were treated for 2 cycles. The clinical efficacy and nutritional compliance rate after treatment of patients in the two groups, the levels of hemoglobin (Hb), albumin (ALB), prealbumin (PA), percentage of CD4+ , CD8+ and CD4+ /CD8+ ratio before and after treatment, as well as the occurrence of adverse reactions during treatment of patients in th two groups were compared. Results? The difference of the short-term efficacy after treatment and the incidence of adverse reactions of nausea, vomiting with International Evaluation System for ADRs of chemotherapeutic drugs for cancer ≥?Ⅲ grade of patients between the two groups had no statistical significance (all P >0.05); compared with before treatment, the levels of serum Hb, ALB, PA of patients in the two groups significantly decreased after treatment, and the research group was significantly lower than the control group; the nutritional compliance rate increased significantly, and the research group was significantly higher than the control group; compared with before treatment, the percentage of CD4+ and CD4+ /CD8+ ratio of patients in the research group increased significantly, while those indexes of patients in the control group decreased significantly, and the research group was significantly higher than the control group; the percentage of CD8+ of patients in the research group significantly decreased after treatment, while the percentage of CD8+ of patients in the control group significantly increased, and the research group was significantly lower than the control group; during the treatment period, the incidence of adverse reactions of myelosuppression, abdominal pain and diarrhea with International Evaluation System for ADRs of chemotherapeutic drugs for cancer ≥?Ⅲ grade in the research group were significantly lower than those in the control group (all P <0.05). Conclusion? Enteral nutrition combined with concurrent radiation and chemoradiotherapy in the treatment of locally advanced cervical cancer can effectively improve the clinical therapeutic effect, improve the nutritional status of patients, regulate the immune function, improve the tolerance of treatment, and reduce the occurrence of adverse reactions

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-26
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司